Vericel
VCEL
₹3,471
Share price
-3.84%
Change (1 day)
-19.48%
Change (1 year)
Categories
Vericel (VCEL) Fails to deliver data
Key failure to deliver metrics for Vericel :
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: ₹0.2 M
- Last 3 months FTD volume: ₹3.22 M
- Last year FTD volume: ₹3.22 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Vericel (VCEL) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Vericel (VCEL) - since 2014
Volume in USD (price x number of shares), data since 2014Vericel (VCEL) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | ₹4.65 M | -47.1% |
| 2024 | ₹8.79 M | 60.89% |
| 2023 | ₹5.46 M | -81.1% |
| 2022 | ₹28.93 M | -10.03% |
| 2021 | ₹32.16 M | 570.32% |
| 2020 | ₹4.79 M | 19.16% |
| 2019 | ₹4.02 M | -56.92% |
| 2018 | ₹9.34 M | 268.59% |
| 2017 | ₹2.53 M | -34.66% |
| 2016 | ₹3.88 M | 2025.74% |
| 2015 | ₹0.18 M | 124.06% |
| 2014 | ₹0.08 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Royalty Pharma RPRX | ₹20.2 M | ₹61.3 M | 🇬🇧 UK |
 Neogen NEOG | ₹9.9 M | ₹19.32 M | 🇺🇸 USA |